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Abstract
Quantum dots (QDs) are small nanocrystals widely used for labelling cells in order to enable cell tracking in complex
environments in vitro, ex vivo and in vivo. They present many advantages over traditional fluorescent markers as they are
resistant to photobleaching and have narrow emission spectra. Although QDs have been used effectively in cell tracking
applications, their suitability has been questioned by reports showing they can affect stem cell behaviour and can be
transferred to neighbouring cells. Using a variety of cellular and molecular biology techniques, we have investigated the
effect of QDs on the proliferation and differentiation potential of two stem cell types: mouse embryonic stem cells and
tissue-specific stem cells derived from mouse kidney. We have also tested if QDs released from living or dead cells can be
taken up by neighbouring cells, and we have determined if QDs affect the degree of cell-cell fusion; this information is
critical in order to assess the suitability of QDs for stem cell tracking. We show here that QDs have no effect on the viability,
proliferation or differentiation potential of the two stem cell types. Furthermore, we show that the extent of transfer of QDs
to neighbouring cells is,4%, and that QDs do not increase the degree of cell-cell fusion. However, although the QDs have a
high labelling efficiency (.85%), they are rapidly depleted from both stem cell populations. Taken together, our results
suggest that QDs are effective cell labelling probes that are suitable for short-term stem cell tracking.
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Introduction
Quantum dots (QDs) are fluorescent semiconductor nanocrys-
tals, which due to their optical properties, have the potential to be
used in a variety of biomedical applications [1]. The wavelength of
light emitted by the QDs is dependent on size, with larger QDs
emitting in the red part of the spectrum, and smaller QDs emitting
blue light [1]. QDs have a number of advantages over traditional
fluorescent markers, such as green fluorescent protein (GFP). For
instance, they have a wide absorbance and narrow emission
spectrum, which means that QDs of different sizes can be excited
with a single light source and emit at discrete, non-overlapping
wavelengths, making them ideally suited to multiplexing [2,3,4].
Furthermore, they are resistant to photobleaching [5], which
means they have great potential for time-lapse studies. QDs
typically comprise an internal CdSe or CdTe core, surrounded by
a ZnS shell that stabilises the optical properties of the QDs and
prevents the leakage of cytotoxic Cd2+ ions [6]. The behaviour of
the QDs can be regulated by functionalising the ZnS shell. For
instance, to promote cellular uptake, the ZnS can be functionalised
with carboxylic acid groups [7] or positively charged peptides [8].
Alternatively, by functionalising the ZnS shell with an appropriate
high affinity peptide ligand, the QDs can be targeted to surface
receptors of specific cell types [9].
It has been shown previously that QDs can be used to label
mesenchymal stem cells (MSCs), allowing the fate of the cells to be
tracked in vivo following transplantation [10]. QDs are useful for
cell tracking because their optical properties enable them to be
distinguished from background tissue autofluorescence, which can
be a problem when trying to track GFP-labelled cells in adult
tissues. A further advantage is that QD labelling is both rapid and
highly efficient [11], which is of benefit when labelling some
primary cell types that can be difficult to transfect.
However, despite the potential for QDs in cell tracking
experiments, a number of contradictory reports have questioned
their suitability for such applications. For instance, while some
studies have shown that QDs do not affect cell viability [11,12],
others have shown cytotoxic effects [13], and although QDs have
been found to effectively label human MSCs without affecting
their differentiation potential [10], other reports have demon-
strated that QDs inhibit MSCs from undergoing chondrogenesis
[14] and osteogenesis [15]. Furthermore, while it has been
reported that QDs are not readily transferred to unlabelled host
cells [10], it has recently been reported that QDs are excreted
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from some cell types, and can be transferred efficiently to
neighbouring cells [11,12]; this is obviously a major concern in
cell tracking studies as it could lead to false positive results. A
difficulty in comparing these contrasting studies is that either
different stem cell types were used (MSCs [10] or embryonic stem
cells (ESCs) [12]), or in cases where the same stem cell type was
used, the QDs had different surface chemistries (carboxyl groups
[10] or positively charged peptides [11]), or different techniques to
promote QD entry into cells were used (passive uptake [10] or
lipofection [15]).
The aim of this work was to investigate the suitability of
positively charged QDs for stem cell tracking. To this end, we
examined the effect of QDs on the viability, proliferation rate and
differentiation potential of two types of stem cells: mouse
embryonic stem cells and mouse kidney-derived stem cells (KSCs),
a tissue-specific stem cell line isolated from postnatal mouse kidney
[16]. We also examined the extent to which QDs are depleted
from these stem cells as they proliferate in culture, and determined
if QDs released from living or dead cells can be transferred to
unlabelled neighbouring cells. Finally, we investigated if QDs can
be transferred via cell-cell fusion, and if the QDs themselves have
any impact on the extent of cell fusion.
Methods
Ethics statement
The only animal work in this study involved the use of mid-
gestation mouse embryos. Dams and embryos were sacrificed
using schedule 1 procedures, which do not require ethical
approval or a UK Home Office animal licence. Dams were culled
using CO2 incubation followed by cervical dislocation. Embryos
were dissected out from uterine horns and decapitated, and the
kidney rudiments were dissected. These procedures were carried
out at the University of Liverpool’s designated animal facility.
Cell culture
The E14.1 mouse ESC line was originally derived from the
inbred mouse strain 129/Ola in 1985 by Martin Hooper in
Edinburgh, Scotland, UK. The E14.1a ESC line used here was
obtained from the Mark Boyd Laboratory at the University of
Liverpool. The cells were cultured in advanced high glucose
DMEM (Invitrogen, UK) supplemented with 2% FCS (PAA
laboratories, UK), 2 mM L-glutamine (Sigma, UK) and 0.01% (v/
v) 50 mM 2-mercaptoethanol (Invitrogen) on plastic tissue culture
dishes (Nunc, Denmark) coated with 0.1% (w/v) gelatine (Sigma).
Mouse KSCs were generated by Cristina Fuente Mora from
mouse neonatal kidneys in our lab [16]. To generate EGFP+ cells
(KSC-GFP), KSC cells were transduced with an EGFP-expressing
lentivirus under the control of the spleen focus-forming virus
(SFFV) promoter, pseudo-coated with a vesicular-stomatitis-virus
glycoprotein (VSV-G) envelope. HEK293T cells were obtained
from ATCC (Middlesex, UK). KSC and HEK293T cells were
cultured in 10% (v/v) FCS DMEM medium supplemented with
2 mM L-glutamine. Both cell types were passaged every 3 days by
trypsinisation and were cultured at 37uC in a humidified
atmosphere containing 5% CO2.
QD labelling
Cells were labelled with QDs (Invitrogen, QtrackerH Cell
Labelling Kit, Q25021MP) according to the manufacturer’s
instructions. Briefly, QDs were mixed with 200 ml complete
culture medium to give a final concentration of 10 nM and
applied to 16106 cells in suspension. After 60 min incubation at
37uC and 5% CO2, the cells were washed 4X with complete
growth medium and either cultured as usual or used for co-culture
with unlabelled KSC-GFP cells in 2D culture (in vitro studies), or
alternatively, co-cultured with unlabelled mouse E13.5 kidney
rudiment cells (ex vivo 3D study). Where required, mitomycin C
was used to block cell divisions; ESC were treated with 5 mg/ml
mitomycin C (Sigma) for 2 h, and KSC were treated with 20 mg/
ml mitomycin C for 3 h, following which, cells were washed 3X in
PBS and subcultured as usual.
Cell viability and growth
Following QD-labelling, the viability of cells was determined by
trypan blue exclusion assay. Briefly, 0.01 ml of a 0.4% solution of
trypan blue in PBS was added to 0.01 ml of cell suspension and
incubated for 3 mins. The number of viable (unstained) and non-
viable (blue) cells were counted using a haemocytometer and cell
viability (%) was calculated as follows: total number of viable cells/
total number of cells6100. ESC and KSC population growth was
assessed as follows: a total number of 156103 cells were plated at
day 0 and the total numbers present at days 1, 2 and 3 were
determined using a haemocytometer, following which population
growth curves were constructed.
Embryoid body (EB) formation
Following QD labelling, EBs were generated by culturing ESC
in non-adherent petri dishes (Corning, UK). For endodermal
differentiation, ESCs were cultured in high glucose DMEM
(Invitrogen) supplemented with 10% (v/v) FCS (PAA laboratories),
2 mM L-glutamine (Invitrogen) and 0.01% (v/v) 50 mM 2-
mercaptoethanol (Invitrogen). For mesodermal differentiation,
ESCs were cultured in IMDM (Invitrogen) supplemented with
15% (v/v) FCS, 2 mM L-glutamine (Invitrogen), 0.15% (v/v)
100 mM monothioglycerol (Sigma), 1% 100X insulin-transferin-
selenium (Sigma) and 0.1% (v/v) 500 mM ascorbic acid (Sigma).
Both types of EB were collected for qPCR analysis following 4 and
7 days in culture.
qPCR
Total RNA was extracted from cells and EBs using TRIzol
reagent (Invitrogen) according to manufacturer’s instructions.
Following treatment with DNase1 (Promega, UK), the RNA was
reverse transcribed using random hexamers (Thermo Scientific,
Massachusetts) and Superscript III (Invitrogen). SYBR green-
based qPCR was performed using KAPA Sybr Fast (Labtech, UK)
and a RotorGene RG-3000 (Corbett Research, UK). The analysis
was performed on 3 replicates, and the relative quantification of
qPCR data for target gene expression in QD-labelled cells was
normalised to endogenous reference gene expression (GAPDH),
relative to untreated control cells [17]. Cycling parameters were:
1 cycle of 95uC/5 min, 35 cycles of 95uC/6 sec, 58uC/30 sec,
72uC/30 sec. Primers used are listed in Table 1.
Kidney rudiment culture
Chimeric kidney rudiments from E13.5 mouse embryos were
cultured based on the method recently described by Unbekandt
and Davies [18]. Single cell suspensions were produced from
freshly isolated rudiments by trypsinisation and mechanical
dissociation. QD-labelled KSC-GFP cells and unlabelled rudiment
cells were counted using a haemocytometer and mixed in a 1 to 8
ratio. Cells were centrifuged at 14006 g for 3 min, the pellets
transferred onto Isopore membrane filters (Millipore) on metal
grids, and then cultured for up to 7 days in a humidified incubator
at 37uC and 5% CO2. For the first 24 h of incubation the Y27632
Rho kinase (ROCK) inhibitor (Chemicon Int., Massachusetts) was
QDs and Stem Cells
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applied at a final concentration of 5 mM. Medium was changed
every second day. Samples were fixed in 4% (w/v) paraformal-
dehyde (PFA) for subsequent immunostaining.
Immunostaining
For immunostaining, cells were fixed in 4% (w/v) PFA, washed
3X in PBS, and then incubated for 1 h at room temperature in
blocking solution (10% (v/v) goat serum, 0.1% (w/v) Triton X100
in PBS). Primary antibodies (Table 2) were applied overnight at
4uC in 1% (v/v) goat serum, 0.1% (w/v) Triton X100 in PBS. The
following day, cells were washed 3X in PBS and incubated with
secondary antibodies (Table 2) in 1% (v/v) goat serum, 0.1% (w/v)
Triton X in PBS for 2 h at room temperature in the dark, then
washed 3X in PBS and incubated with 0. 05 ng/ml DAPI (4,6-
diamino-2-phenylindole dihydrochloride, Invitrogen) for 5 min at
room temperature in the dark. Cells were analysed either with
Leica fluorescent microscope (Leica DMIL, Leica, Germany) or
Leica confocal microscope (LEICA AOBS SP2).
QD exclusion assay and spectrophotometric analysis
ESC and KSC were labelled with QD as described above and
plated onto 3.5 cm dishes (Nunc, Denmark). Cells were allowed to
attach for 4 h, following which the culture medium was changed
in order to remove any unattached cells. Medium was collected
from cells after 48 h, and QDs were collected using a previously
described method [12]. In brief, the culture medium was filtered
through 0.22 mm syringe filter (Millipore, UK) and then
centrifuged at 3500 g for 6 min. Pelleted QDs were either
resuspended in 5 ml of component B from QD Tracker kit
(Invitrogen), or were immediately resuspended in fresh culture
medium and mixed with 16106 ESCs or KSCs. Following 1 h
incubation with recovered QDs, cells were washed 4 X with
culture medium, fixed in 2% (w/v) PFA and analysed by flow
cytometry. For spectrophotometric analysis cells were labelled with
QD as usual and washed 4X. Following each wash the medium
was recovered. Medium was also recovered from QD-labelled cells
following 48 h in culture; the medium was collected into tubes,
centrifuged at 2000 rpm for 3 min and transferred into fresh tubes
for spectrophotometric analysis. The analysis was performed using
Cary Eclipse VARIAN Fluorescence Spectrophotometer (Agilent
Technologies UK Limited, UK) using Cary Eclipse Software. The
amount of QD in nM was established by comparison of sample
fluorescence to standard curve readings.
Cell lysis
106 QD-labelled cells were cultured for 24 h after which they
were trypsinised as described above and incubated in 10% (v/v)
dimethyl sulfoxide (DMSO) in PBS for 3 h at 37uC. Resultant cell
debris was vortexed for 30 sec and transferred into 3.5 cm dishes
containing 56104 KSC-GFPs and cultured for 24 h. Cells were
then washed 2 X with PBS, trypsinised and fixed in 2% (w/v) PFA
for flow cytometry analysis.
Cell fusion assay
The ability of QDs to increase the incidence of cell fusion was
investigated using HEK 293T cells transfected with tandem dimer
Tomato (tdTomato – HEK293-Tomato). The tdTomato plasmid
was kindly provided by Dr Diana Moss (University of Liverpool).
The cells were transfected using Lipofectamine 2000 (Invitrogen)
after seeding for 1 day to obtain 90% confluency. Lipofectamine
2000 and DNA were diluted separately in Advanced DMEM
(Invitrogen), incubated for 5 min, before mixing and incubating
for a further 20 min at room temperature according to
manufacturer’s instructions. The mix was then added to 56105
cells for 24 h, after which the cells were washed with 16PBS and
trypsinised as described before and labelled with QDs. 56104
labelled or unlabelled cells were then co-cultured with 56104
KSC-GFP cells and their fusion determined after 24 h and 72 h
culture using fluorescence microscopy and flow cytometry.
Flow cytometry
QD-labelled cells were either fixed immediately after labelling
(day 0) or cultured for up to three days. At specified time points the
cells were trypsinised as usual and fixed in 2% (w/v) PFA and kept
at 4uC for a maximum of 7 days until analysed with a flow
cytometer (LSR II, BD Biosciences, Belgium). The data were
Table 1. Primers used in this study.
Gene Primers Product size
Brachyury F: CATCGGAACAGCTCTCCAACCTAT
R: GTGGGCTGGCGTTATGACTCA
136 bp
Gapdh F: TGAAGCAGGCATCTGAGGG
R: CGAAGGTGGAAGAGTGGGAG
102 bp
Gata6 F: CAAGATGAATGGCCTCAGCAG
R: TGGTGGTGGTGTGACAGTTGG
101 bp
Oct4 F: TGGAGACTTTGCAGCCTGAG
R: CTTCAGCAGCTTGGCAAACTG
188 bp
Pax6 F: GAGAAGAGAAGAGAAACTGAGGAACCAGA
R: ATGGGTTGGCAAAGCACTGTACG
201 bp
Synaptopodin F: GCCAGGGACCAGCCAGATA
R: AGGAGCCCAGGCCTTCTCT
73 bp
Wt1 F: CCAGTGTAAAACTTGTCAGCGA
R: TGGGATGCTGGACTGTCT
234 bp
doi:10.1371/journal.pone.0032650.t001
Table 2. Primary and secondary antibodies.
Name Type Concentration Supplier
Primary
antibody
Oct4 Mouse monoclonal IgG2B 1:500 Santa Cruz, California,
USA
Wt1 Mouse monoclonal IgG1 1:500 Upstate Massachusetts, USA
Synaptopodin Mouse monoclonal IgG1 1:4 Acris, Germany
Secondary
antibody
Goat a Mouse IgG1 – 488 1:500 Invitrogen
Goat a Mouse IgG2B – 488 1:1000 Invitrogen
doi:10.1371/journal.pone.0032650.t002
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analysed using BD FACSDiva software (BD Biosciences). For each
analysis (3 replicates) the data from 104 cells were gathered. The
tdTomato emitted at 581 nm and QDs emitted at 655 nm; the
compensation was set according to appropriate controls.
Time lapse studies
ESC and KSC, with and without mitomycin C (MMC)
treatment, were labelled with QD as described above and plated
onto 3.5 cm dish (Greiner Bio One Ltd). The cells were imaged
using a Zeiss LSM 510 confocal laser scanning system mounted on
a Zeiss Axiovert 200 M (Carl Zeiss, Germany), with temperature
controlled at 37uC and concentration of CO2 at 5.0%. For all
acquisition settings, the main beam splitter was HFT 488/543.
QDs were excited at 543 nm light and detected with a 560 nm
longpass (LP) filter. Phase contrast images were recorded
simultaneously with the red fluorescence in the transmission
channel. Data capture was carried out every 10 min with Zeiss
AIM software- (Zeiss, Germany) using the Auto-time series macro
[19] and concatenated for each location. The obtained movies
were then formatted using Pinnacle Studio software (Pinnacle
Systems Ltd., UK).
Statistical analysis
For all statistical data analyses, three independent replicates
were used (n= 3). For image analysis, 6 different fields of view per
sample were randomly selected. All data are shown as a mean +/
2 of standard error. Data sets were compared using Student’s t test
with p,0.05 considered as significant.
Results and Discussion
QDs do not affect the viability or growth rate of ESCs and
KSCs
To investigate the effect of QDs on the viability of ESCs and
KSCs, both cell types were labelled with QDs for one hour,
following which viability was determined by trypan blue exclusion.
The results showed that QDs had no immediate effect on the
viability of either ESCs or KSCs when compared to unlabelled
controls (Figure 1A). To investigate if QDs had any effect on
population growth, the number of ESCs and KSCs were counted
over a 3 day period. QD labelling had no effect on the population
growth of either stem cell type when compared to unlabelled
controls (Figure 1B and C). It has been reported previously that
QDs can be cytotoxic due to the release of Cd2+ ions from the
CdSe or CdTe core of the QD [20]. However, the QDs used in
this study were coated with a ZnS shell, which has been reported
to prevent the release of Cd2+ ions thereby circumventing
cytotoxic effects [6]. Thus, the lack of toxicity we demonstrate
here for the ESC and KSC cells is consistent with other studies
using ZnS-coated QDs on other cell types [11,12], and so the
previously reported cytotoxicity [15] is therefore likely to reflect
the QD chemical composition or carrier vehicle (liposome-based
transfection [15]) rather than being inherent to all QDs.
QDs do not affect the differentiation potential of ESCs
and KSCs
Quantitative PCR (qPCR) analysis of ESCs on the first and
third days following QD labelling showed that mRNA levels of the
pluripotency transcription factor, Oct4, were not significantly
different in labelled cells compared to controls (Figure 2A).
Furthermore, the majority of QD-labelled cells displayed Oct4
immunoreactivity, confirming that the QDs do not appear to
promote ESC differentiation when cultured under standard self-
renewal conditions (Figure 2B). To investigate if QDs affected the
ability of ESCs to differentiate, following QD-labelling, cells were
cultured in suspension to promote the formation of embryoid
bodies (EBs), using media optimized for either endoderm
differentiation [21] or mesoderm differentiation [22]. After 4 days
in the endoderm-promoting medium, both control and QD-
labelled ESCs generated EBs with a thick outer layer of endoderm
overlying a distinct basement membrane. Correspondingly, the
mesoderm-promoting conditions resulted in QD-labelled EBs that
were indistinguishable from controls, having only a thin ring of
outer endoderm cells (Figure 2C). The diameters of the QD-
labelled EBs was not significantly different from that of controls
under either culture condition (Figure 2D). qPCR analysis of EBs
at 7 days showed that expression levels of the endoderm-specific
gene, Gata6 [23], the mesoderm-specific gene, brachyury [24] and
the ectoderm-specific gene, Pax6 [25], were not significantly
different in EBs generated from QD-labelled ESCs compared to
controls (Figure 2E). To investigate the effect of QDs on KSC
differentiation, qPCR analysis showed that mRNA levels of the
Wt1 KSC marker [16] were not significantly different between
QD-labelled KSCs and controls (Figure 3A). Furthermore, the
majority of QD-labelled cells displayed Wt1 immunoreactivity
(Figure 3B). Additionally, mRNA levels (Figure 3C) and
Figure 1. Cell viability and population growth following QD labelling. A) KSC and ESC viability measured by trypan blue exclusion from QD-
labelled (QD+ - black bar) and unlabelled cells (QD2 - grey bar) immediately after QD labelling. B) Population growth curves for unlabelled control
ESCs (ESC QD2) and QD-labelled ESCs (ESC QD+). C) Population growth curves for unlabelled control KSCs (KSC QD2) and QD-labelled KSCs (KSC
QD+); n = 3 for each experiment.
doi:10.1371/journal.pone.0032650.g001
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immunoreactivity (Figure 3D) of the podocyte-specific marker
synaptopodin expressed by spontaneously differentiating KSC [16]
were not significantly different in QD-labelled KSC compared to
unlabelled controls. The increased number of QD aggregates in
the podocyte-like cells compared to the KSCs was likely due to the
fact that podocytes are terminally differentiated cells that do not
proliferate (Figure 3D). Taken together, these results show that
QDs do not appear to affect ESC or KSC potency. It has been
reported previously that QDs inhibited the differentiation of
MSCs to osteoblasts and chondrocytes [14,15]. It should be noted
that the QDs used in those studies were negatively charged and
were delivered to the cells using liposome-based transfection
[14,15], while it has been shown recently that positively charged
QDs, similar to those used in the current study, did not inhibit
MSC osteogenesis [11]. It is therefore possible that in addition to
any effects of QD surface chemistry [20], the delivery method
might have the potential to affect stem cell differentiation.
QDs have a high labelling efficiency but are depleted
rapidly from ESCs and KSCs
In order for QDs to be useful for cell tracking, it is necessary
that a reasonable proportion of cells within the population retain
their label throughout the time course of the experiment. To
Figure 2. QDs do not affect the expression of pluripotency and lineage-specific markers in mouse ESCs. A) QPCR analysis of Oct4mRNA
level in unlabelled (ESC QD2) and labelled (ESC QD+) after 1 and 3 days in culture. B) Immunofluorescent staining for Oct4 protein in both ESC QD2
and ESC QD+ cells showed nuclear localisation of Oct4 (green); white arrows in lower panel indicate Oct4+ QD+ cells. Nuclei are stained with DAPI
(blue). Scale bar 250 mm. C) Top panel shows that following 4 days of culture under conditions that promote the differentiation of extra-embryonic
endoderm, EBs derived from both control (QD2) and labelled (QD+) ESCs developed a thick layer of extra-embryonic endoderm at the EB periphery.
Bottom panel shows that following 4 days of culture under conditions that promote mesoderm differentiation, EBs derived from both QD2 and QD+
ESCs developed a thin layer of outer extra-embryonic endoderm. Scale bar 2100 mm. Images in the right-hand panel show the presence of QDs in 4
day EBs. D) QDs did not affect the size of the EBs under both endoderm- and mesoderm-promoting conditions. E) qPCR analysis of the endoderm-
specific gene, Gata6 mRNA, the mesoderm-specific gene, brachyury (Bra) and the ectoderm specific gene, Pax6, showed no significant difference in
expression levels between EBs generated from QD2 ESC and those generated from QD+ ESC. The reference gene used for qPCR was Gapdh; n = 3 for
each experiment.
doi:10.1371/journal.pone.0032650.g002
Figure 3. QDs do not affect the expression of lineage-specific markers in mouse KSCs. A) QPCR analysis of the KSC marker, Wt1 mRNA, in
unlabelled (QD2) and labelled KSCs (QD+) after 2 days in culture did not show any significant difference in expression levels. B) Immunofluorescent
staining for Wt1 protein (green) showed no difference in expression between control and QD-labelled cells. Nuclei are stained with DAPI (blue). Scale
bar 250 mm. C) QPCR analysis of the podocyte-specific marker, synaptopodin, mRNA in unlabelled (QD2) and labelled KSCs (QD+) after 2 days in
culture did not show any significant difference in expression levels. D) Immunostaining for synaptopodin (green) showed nuclear and membrane
localisation in both unlabelled (QD2) and labelled (QD+) podocyte-like cells (yellow arrow). Nuclei are stained with DAPI (blue). Scale bar250 mm. The
reference gene used for QPCR was Gapdh; n = 3 for each experiment.
doi:10.1371/journal.pone.0032650.g003
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investigate if ESCs and KSCs retained the QDs, the cells were
imaged daily for a period of 3 days. At day 0 (2 hours following
labeling), the majority of ESCs and KSCs were labelled, and it was
found that the QDs were localised to a few large aggregates in
close proximity to the nucleus (Figure S1). The staining pattern of
the QDs suggested that they were localised to late endosomes and
lysosomes, as previously described [12]. By day 3, the proportion
of labelled cells in both cell populations was noticeably reduced;
FACS analysis showed that about 85% of both stem cell types
were labelled at day 0, but by day 3, the percentage of labelled
ESCs and KSCs had fallen to 10% and 40%, respectively
(Figure 4A and B).
To determine if QD depletion was due to cell division,
mitomycin C was used to block cell proliferation and the number
of QD-labelled cells was determined using flow cytometry. If the
decrease in the number of QD-labelled cells was entirely due to
signal dilution following cell division, it would be expected that
mitomycin C treatment should prevent signal loss. In the presence
of mitomycin C, the percentage of QD-labelled KSCs did not
significantly decrease between days 1 and 3, leading to the
conclusion that cell division was the main reason for the reduction
in the number of labelled KSCs (Figure 4C). In contrast, the
mitomycin C had a negative impact on ESC resulting in excessive
cell death (Figure 5F, Movie S4); therefore, FACS analysis beyond
day 1 was not possible (Figure 4D). To confirm that QD loss over
time is due to cell division rather than excretion, as suggested by Pi
et al. [12], we have investigated the amount of QD in the medium
after 2 days in culture using fluorometry. We found that the
amount of QD present in the medium after 2 days in culture was
negligible (,0.15 nM), suggesting that the QD are not released
from cells (Figure 5A and 5B). In order to confirm the above
results, time lapse studies were performed of QD-labelled ESC and
KSC, both with and without treatment with mitomycin C (MMC).
They revealed that over the time-course of the experiment, neither
KSC, nor ESC, appeared to excrete QDs (Movie S1, S2 and S3).
Moreover, upon MMC-induced cell death of ESC, we did not
Figure 4. ESC and KSC do not excrete QD. A–B) Following 3 days in culture about 40% of KSCs were QD-labelled (A) and only 10% of ESC were
QD-labelled (B). C–D) Treatment with mitomycin C (MMC) inhibited QD loss from KSC over a 3 day time course (C) and from ESC over a 24 h time
course (note that after 24 h, MMC-treated ESCs had undergone cell death and analysis at later time points was not possible) (D). E–F) The
proliferation growth curve of QD-labelled and unlabelled KSC (E) and ESC (F) following treatment with MMC.
doi:10.1371/journal.pone.0032650.g004
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observe any QD release (Movie S4). Taken together, these results
show that QDs are diluted in ESCs and KSCs by cell division and
not by QD excretion from cells. However, due to the fact that this
depletion is quite rapid, QDs are only suitable for relatively short-
term tracking.
QDs do not readily transfer to neighbouring cells in 2D
co-culture
For cell tracking experiments, it is important to establish if any
QDs could be transferred from labelled cells to unlabelled
neighbouring cells, as this could lead to false results. Although the
medium collected from labelled cells after 48 h of culture contains
very low amounts of QDs (,0.15 nM) (Figure 5A, 5B), we
nevertheless collected this medium from QD-labelled ESC and
KSC to ascertain if any QDs present were able to label a fresh batch
of ESCs and KSCs, respectively. Flow cytometry showed that QD-
containing medium collected from ESCs labelled,4% of cells, while
medium collected from KSCs labelled only ,2% of cells (Figure 5C
and 5D). To investigate if the reason for poor re-labelling efficiency
was that the coating peptide required for delivering the QDs inside
the cells had been modified or removed within the intracellular
environment, the experiment was repeated, but prior to re-labelling,
QDs collected from the culture medium were incubated in fresh
coating peptide. It was found that the re-application of coating
peptide did not significantly affect the results (data not shown).
Our findings are markedly different from those described in a
recent report by Pi et al., where it was shown that QDs excreted by
ESCs could re-label .20% of a fresh ESC population [12].
However, in the Pi et al. study, only one wash step was used to
remove the QDs from the cell suspension following re-labelling,
whereas we routinely perform four washes. It is thus possible that
the excess of QD aggregates in the Pi et al. study might have
remained stuck to the outside of the cells, leading to false positive
results when the cells were analysed using flow cytometry [12]. To
investigate if QDs could be transferred to neighbouring cells under
direct co-culture conditions, QD-labelled cells were mixed with a
population of KSCs that constitutively expressed GFP (KSC-GFP
cells). Following 24 h of co-culture, very few GFP+ cells contained
QDs (Figure 6A, B and C) and flow cytometric analysis showed
that the percentage of QD-labelled GFP+ cells was ,4%
(Figure 6D). Our findings contrast with those of Ranjbarvarizi et
al, who showed 100% transfer efficiency of QDs from labelled cells
derived from umbilical cord blood and bone marrow to
neighbouring cells in co-culture experiments [11]. It has been
reported that the behaviour of QDs inside cells can vary
depending on the size of the QDs and their surface chemistry
Figure 5. Flow cytometric analysis shows that QDs excluded from cells display a poor re-labelling efficiency. A–B) Fluorometer
analysis of the medium collected following each of the 4 washes immediately after QD labelling, and of medium collected from KSC (A) and ESC (B)
following 48 h of culture. Note that the medium was not filtered, only centrifuged in order to eliminate cells from the suspension; n = 3 for each
timepoint. C) QDs (0.134 nM) collected from ESC culture medium following 48 h of initial labelling, labelled 4.45+/20.12% of a fresh ESC population.
D) QDs (0.134 nM) collected from KSC culture medium following 48 h of initial labelling, labelled 2.4+/20.3% of a fresh KSC population; n = 3 for each
experiment.
doi:10.1371/journal.pone.0032650.g005
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Figure 6. Co-culture of QD-labelled KSC and KSC-GFP cells showed minimal QD transfer. A–C) Following 24 h co-culture, very few GFP+
cells were labelled with QDs (arrowheads in C); A) QD+ cells (red); GFP+ cells (green); B) phase contrast and fluorescence overlay; C) Zoom of boxed
area in B. D) Flow cytometric analysis shows that following 24 h of co-culture, only 3% (+/20.09%) of cells were GFP+QD+; n = 3.
doi:10.1371/journal.pone.0032650.g006
Figure 7. QD transfer from KSC-GFP cells into mouse foetal kidney cells in 3D ex vivo co-culture is negligible. A) Confocal microscopy
of chimeric kidney rudiments shows that few host cells become labelled with QDs over a 3 day time course; (DAPI, blue; GFP, green; QDs, red). Note
that in most fields of view, no GFP2 QD+ cells were present. The presented images have been selected to show rare GFP2 QD+ cells. Scale bar, 10 mm.
B) Statistical analysis of QD transfer shows no significant difference in numbers of GFP2QD+ cells from day 0 (1.8+/20.5%) and day 3 (2.5+/20.4%) of
culture; p.0.1 (n = 3).
doi:10.1371/journal.pone.0032650.g007
QDs and Stem Cells
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e32650
[26]. However, the QDs used in the current study were coated
with the same positively charged peptides as those used by
Ranjbarvarizi et al. [11]. Furthermore, although the QDs used
here (QD 655 nm) were of a different size, this is unlikely to
account for the differences in results, as Ranjbarvarizi et al.
observed QD transfer to unlabelled cells when both smaller
(585 nm) and larger (800 nm) QDs were used. Given that human
umbilical cord blood-derived CD34+ cells, such as those used by
Ranjbarvarizi et al. [11], display a high incidence of cell-cell fusion
in 2D culture [27], then cell-specific fusion may account for the
differing observations. Consistent with this notion, it has recently
been shown that QDs did not transfer to neighbouring human
bone marrow-derived MSCs [10].
In ex vivo transplantation studies, the extent of QD
transfer from grafted cells to host cells is negligible
The low level of QD transfer we observed in 2D KSC co-
culture could be due to the fact that under these conditions there is
only a limited degree of cell-cell contact between the QD-labelled
and unlabelled GFP+ cells (Figure 6A and B). It was therefore
important to determine the degree of QD transfer under
conditions where the QD-labelled cells are completely surrounded
by unlabelled host cells using organ culture. To this end, KSC-
GFP cells were labelled with QDs, and mixed with freshly isolated
mouse foetal kidney cells in order to form a chimeric rudiment
[18]. The percentage of host rudiment cells that became labelled
with QDs was determined daily over a 3 day culture period. The
results showed that at day 0, the percentage of QD-labelled host
cells was 1.8+/20.5%, and importantly, only 2.5+/20.4% of host
cells were labelled by day 3 (Figure 7). Furthermore, the
percentage of QD-labelled KSC-GFP cells at day 0 was 99+/
20.1%, and remained at 96+/20.6% by day 3 (Figure 7). This
result was dramatically different to that observed in 2D culture,
where it was observed that only 40% of KSCs remained labelled
with QDs following a 3 day culture period. The most likely
explanation is that the proliferation rate of the KSCs is much
slower within the kidney rudiment than in 2D culture.
QDs released following cell death are not readily
transferred to neighbouring cells
A potential problem with most of the commonly used labelling
methods for cell tracking is that if the grafted cell dies, the label
could be taken up by neighbouring host cells, leading to false
positive results. The time lapse studies of ESC MMC treated cells
showed cell death (Movie S4) and lack of QD release to medium;
however these cells are not in close proximity to healthy cells.
Therefore to investigate if QDs released from dead cells can be
transferred to neighbouring cells, QD-labelled ESCs and KSCs
were induced to undergo cell death by incubation in 10% dimethyl
sulfoxide (DMSO) for 3 hours at 37uC. DMSO increases the
permeability of the cell and intracellular membranes [28],
especially at high temperature, and has marked cytotoxic effects
following 2–3 h incubation for both KSC (Figure 8A and B) and
ESC (not shown). Following DMSO treatment, the resultant cell
debris was then co-cultured with a population of KSC-GFP cells
for 24 h. Flow cytometry showed that irrespective of whether the
KSC-GFPs were cultured with cell debris derived from QD-
labelled ESCs or KSCs, the percentage of KSC-GFPs that became
QD-labelled was ,5% (Figure 8C and D).
QDs do not increase the degree of cell-cell fusion
It has been well-established that some cell types can fuse with
host cells following transplantation [29,30], leading to false positive
Figure 8. QDs released following cell death are not readily transferred to neighbouring cells. (A, B) Phase contrast (A) and fluorescent (B)
image of QD-labelled KSC following treatment with DMSO. (C, D) Flow cytometric analysis showed that relatively few QDs released by dead cells
were taken up by GFP-labelled KSC; QD from ESCs showed an average uptake of 4.4+/23.3% (n = 3) (C) and QDs from KSC, 3.4+/21.2% (n= 3) (D).
Scale bars, 20 mm.
doi:10.1371/journal.pone.0032650.g008
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results. It is clear that the extent of fusion is dependent on a
number of factors, including the type of cell that is transplanted,
the target organ, and the condition of the host tissue. However, to
our knowledge, the effect of the labelling reagent itself on cell
fusion has not previously been studied. To investigate if QD-
labelling increases the incidence of cell-cell fusion, human
embryonic kidney (HEK293) cells expressing the tdTomato
fluorescent protein (HEK293-tdTomato), were labelled with
QDs and co-cultured with KSC-GFP cells. Controls consisted of
co-cultures of unlabelled HEK293-tdTomato cells and KSC-GFP
cells. The extent of fusion was investigated using flow cytometry
following 24 h and 72 h of co-culture by determining the
percentage of cells displaying both red (tdTomato) and green
(GFP) fluorescence. It was found that the extent of cell-cell fusion
in controls was negligible (,2%), and did not increase following
QD labelling of the HEK293-tdTomato cells (Figure 9). Therefore
it can be concluded that labelling with QDs does not affect cell
fusion.
Conclusion
In this study we have investigated the feasibility of using QDs to
track mouse ESCs and KSCs. We found that QDs had a high
labelling efficiency and had no effect on the viability or
differentiation potential of ESCs and KSCs, but were rapidly
depleted from both stem cell types when cultured under self-
renewal conditions in 2D culture, indicating that they are only
suitable for short-term tracking in rapidly proliferating cells. In
contrast, when QD-labelled cells were cultured in 3D organ
culture, conditions in which the stem cells are expected to
differentiate, the degree of QD depletion was minimal; this was
likely due to the lower proliferation rate of the cells following
differentiation. Cell division was the main cause of QD depletion
Figure 9. QDs do not increase cell-cell fusion. A) HEK-293T cells expressing tdTomato were labelled with QDs and co-cultured with KSC-GFP
cells. Flow cytometric analysis showed that QDs did not increase cell-cell fusion over a 3 day time course. B) Flow cytometry data were collected for
16104 events for gated population, P1. C–F) Representative flow cytometry graphs showing the percentage of fused cells in controls (QD2) at day 1
(1.2+/20.1%; C) and day 3 (0.8+/20.2%; D) of culture; and in QD-labelled cells (QD+) at day 1 (1.3+/20.1%; E) and day 3 (0.7+/20.03%; F).
doi:10.1371/journal.pone.0032650.g009
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in KSCs and ESCs. QDs were not released into the extracellular
environment through excretion, or due to cell death, and were not
readily transferred to neighbouring cells. Furthermore, the QDs
had no effect on the incidence of fusion. Taken together, our
results show that the QDs used in this study (655 nm CdSe/ZnS
dots coated with positively charged peptides) are suitable for short-
term tracking of mouse ESCs and KSCs. However, given that QD
behaviour can vary depending on size and surface chemistry,
accompanied with the fact that some cell types, such as CD34+
cells, have a high propensity for cell-cell fusion, it is important to
establish the effect of QDs on cell behaviour and the extent of QD
transfer for each particular QD and stem cell type.
Supporting Information
Figure S1 Photomicrograph of KSC and ESC labelled
with QD.
(TIF)
Movie S1 24 h time lapse confocal microscopy showing
the behaviour of QD-labelled KSC in culture. White
arrows indicate some dividing cells. Proliferating cells round up
before dividing to generate two daughter cells, all of which were
labelled with QDs.
(AVI)
Movie S2 24 h time lapse confocal microscopy showing
the behaviour of QD-labelled KSC following treatment
with mitomycin C. These cells do not divide, only migrate
around the dish. All cells remain labelled with QDs.
(AVI)
Movie S3 24 h time lapse confocal microscopy showing
the behaviour of QD-labelled ESC in culture. The white
arrow indicates an ESC undergoing cell division. The daughter
cells later combine with a larger colony. It is clear that not all cells
are labelled at the end of the 24 h time course. The green arrows
indicate migrating MEF cells.
(AVI)
Movie S4 24 h time lapse confocal microscopy showing
the behaviour of QD-labelled ESC following treatment
with mitomycin C. These ESC do not divide and many of them
are already dead at the start of the time course (,7 h post plating).
Yellow arrows indicate dying cells. In most cases the dead cells
appear to retain their QDs.
(AVI)
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